BioCentury
ARTICLE | Clinical News

NewGen, Kanion preclinical data

April 29, 2013 7:00 AM UTC

In a mouse xenograft model of GBM, NT-113 significantly increased survival vs. controls. Data were presented at the American Association for Cancer Research meeting in Washington, D.C. The company pla...